Vaxine’s COVID-19 vaccine technology has progressed to the final stages of a human clinical trial, after strong preliminary results demonstrating its ability to prevent coronavirus infections in animal models.

This highly effective protein-based vaccine can be manufactured on a large scale and remain stable in normal refrigerated conditions.

Read this full article here: Australian-made coronavirus vaccine COVAX-19 shows promise in trials